检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Prognostic Impact of Body Composition Phenotypes in Non-small Cell Lung Cancer Patients Receiving First-Line Pembrolizumab

I. Trestini,M. Cintoni, A. Caldart, A. Dodi, M. Sposito, D. Kadrija,L. Belluomini, J. Menis, E. Vita, I. Sperduti, A. Drudi, G. Aluffi, M. Todesco, D. Tregnago,A. Avancini,M. D'Onofrio,M. C. Mele,G. Tortora,M. Milella,E. Bria,S. Pilotto

JOURNAL OF THORACIC ONCOLOGY（2022）

引用 0|浏览1
暂无评分
关键词
immune-checkpoint inhibitor, non-small-cell lung cancer, body composition
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要